News

If you’re pregnant or hoping to become pregnant, it’s natural to have questions about your medications. And if you’re taking ...
THE price of Mounjaro is set to soar, The Sun revealed yesterday – leaving slimmers desperate and worried at how they will ...
Mounjaro, one of the UK’s most popular weight-loss jabs, is set to become more expensive for private patients after Eli Lilly ...
Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.
Digestion issues, fatigue, and high costs haven’t stopped some from finding power and transformation through GLP-1 ...
Once the golden child of the weight-loss boom, the Danish drugmaker now faces a painful financial slimming of its own.
Aug 14 (Reuters) - More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 ...
WeightWatchers is now only offering Wegovy while other telehealth providers defiantly hang on to compounded alternatives.
Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and ...
iOS 26 and iPadOS 26 public beta: Everything you need to know about the new Apple updates Exciting changes are coming to your iPhone this fall, including a new aesthetic called Liquid Glass.
You've likely heard about glucagon-like peptide-1 agonists – usually referred to as GLP-1 medications, and more wildly ...